(19)
(11) EP 1 527 053 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
08.03.2006 Bulletin 2006/10

(45) Mention of the grant of the patent:
07.12.2005 Bulletin 2005/49

(21) Application number: 03784405.7

(22) Date of filing: 05.08.2003
(51) International Patent Classification (IPC): 
C07D 249/08(1985.01)
C07D 491/052(1985.01)
 C07D 405/12(1990.01)
C07D 403/06(1990.01)
(86) International application number:
PCT/IB2003/003540
(87) International publication number:
WO 2004/014877 (19.02.2004 Gazette 2004/08)

(54)

PROCESS FOR PREPARING RIZATRIPTAN

VERFAHREN ZUR HERSTELLUNG VON RIZATRIPTAN

PROCEDE DE PREPARATION DE RIZATRIPTAN

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 07.08.2002 ES 200201874

(43) Date of publication of application:
04.05.2005 Bulletin 2005/18

(73) Proprietor: INKE, S.A.
08755 Castellbisbal (ES)

(72) Inventors:
  • DALMASES BARJOAN, Pere
    E-08980 Sant Feliu de Llobregat (ES)
  • ARMENGOL ASPARO, Montserrat
    E-08970 Sant Joan Despi (ES)

(74) Representative: Ponti Sales, Adelaida et al
Oficina Ponti C. Consell de Cent, 322
08007 Barcelona
08007 Barcelona (ES)


(56) References cited: : 
EP-A- 0 497 512
WO-A-94/02476
WO-A-98/06725
ES-A- 2 033 578
 WO-A-01/34561
WO-A-95/32197
ES-A- 2 033 577
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).